Allergan Recalls INFed Iron Dextran Injection Due to Iron Content Issues
Allergan recalls INFed (Iron Dextran Injection USP) 100 mg elemental iron/2 mL (50 mg/mL) due to failed stability tests. This medication, prescribed only, may have incorrect iron levels.
Lower-risk recall
Failed Stability Specification: out of specification for iron content.
Contact the company
What happened, in plain English
Allergan is recalling a specific iron injection product (INFed) because lab tests showed it doesn't contain the correct amount of iron. This could lead to ineffective treatment if used as directed. Read more at govinfonow.com/recall/39435-allergan-recalls-infed-iron-dextran-injection-due-to-iron-content.
Source Summary by GovInfoNow · govinfonow.com/recall/39435-allergan-recalls-infed-iron-dextran-injection-due-to-iron-content · Updated October 5, 2026 · FDA enforcement record: FDA #D-0282-2019
Cite this page
“Allergan Recalls INFed Iron Dextran Injection Due to Iron Content Issues.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39435-allergan-recalls-infed-iron-dextran-injection-due-to-iron-content. Based on FDA recall #D-0282-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0282-2019%22&limit=1).
Why it’s dangerous
The medication failed stability tests, meaning it may not contain the correct iron concentration. This could result in the injection being less effective than intended for treating iron deficiency anemia.
Who’s affected
People who have been prescribed this iron injection medication by a doctor. Those with iron deficiency anemia who need this treatment are most at risk.
How to tell if you have this one
Look for the product name 'INFed (Iron Dextran Injection USP) 100 mg elemental iron/2 mL (50 mg/mL)'. Check the lot numbers listed: 16W06A through 17W22A, with expiration dates from February 2019 to August 2020.
- Brand
Allergan- Category
Drug
What to do — step by step
Check Product Details
Verify the product name, lot number, and expiration date on the vial to confirm if it's part of the recall.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Product was distributed throughout the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 17 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product safe to use?
The recall indicates the product may not contain the correct iron levels, so it's not recommended for use until the remedy is followed.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0282-2019 (November 8, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0282-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.